Stock listing
MBX Stock Price, News, Filings & Events — Mbx Biosciences, Inc.
Selected listing: MBX · BOATS · USD · US
This page tracks Mbx Biosciences, Inc.'s MBX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MBX:BOATS. MBX:BOATS is the stock-level entry point for investors researching Mbx Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mbx Biosciences, Inc. is a publicly traded company listed under the ticker MBX in the American market. The company has a market capitalization of approximately $2.95 billion. Mbx Biosciences focuses on developing innovative solutions in the biosciences sector.

- Ticker
- MBX:BOATS
- Asset type
- Stock
- Market cap
- $2.84B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Mbx Biosciences, Inc. MBX:BOATS stock context
This page tracks Mbx Biosciences, Inc.'s MBX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MBX:BOATS. MBX:BOATS is the stock-level entry point for investors researching Mbx Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mbx Biosciences, Inc. is a publicly traded company listed under the ticker MBX in the American market. The company has a market capitalization of approximately $2.95 billion. Mbx Biosciences focuses on developing innovative solutions in the biosciences sector.
Latest news from Mbx Biosciences, Inc.
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
September 8, 2026
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyro...
August 27, 2026
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 6, 2026
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
July 13, 2026
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Thera...
June 12, 2026
Mbx Biosciences, Inc. earnings calls
MBX Biosciences, Inc. (MBX) Q3 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
MBX Biosciences, Inc. (MBX) Q2 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
MBX Biosciences, Inc. (MBX) Q1 2025 Earnings Call
February 13, 2025 · Replay with transcript and chapters
Research Mbx Biosciences, Inc.
Mbx Biosciences, Inc. investor report
Review AI stock analysis and investor report context for MBX:BOATS.
Mbx Biosciences, Inc. company profile
View the public company page for Mbx Biosciences, Inc. on 6ix.
Mbx Biosciences, Inc. news
Read company news and market updates connected to Mbx Biosciences, Inc..
Mbx Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Mbx Biosciences, Inc..